DRG 239 Overview

DRG 239 covers inpatient admissions for lower‑extremity amputations related to circulatory system disorders, excluding upper limb and toe, when a Major Complication or Comorbidity is present. This Diagnosis-Related Group applies to complex cases where vascular disease and associated severe comorbid conditions increase resource use. It matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates the relative weight and payment level compared with less severe amputation DRGs. Accurate coding and documentation of the amputation level and major comorbidities drive correct Medicare Severity Diagnosis-Related Group assignment and reimbursement.

• Acute perioperative and limb-salvage intervention trials: studies focusing on optimizing surgical techniques, vascular reconstruction adjuncts, and perioperative management for patients undergoing lower-extremity amputation due to critical limb ischemia and other circulatory disorders with major complications or comorbidities. These studies enroll hospitalized patients with advanced peripheral arterial disease, tissue loss, infection, or failed revascularization who require urgent or planned amputation, and evaluate outcomes such as intraoperative blood loss, wound complication rates, and early mortality. Results inform surgeons and hospital administrators about best practices to reduce inpatient complications, length of stay, and resource utilization for a high-cost DRG population.
• Comparative effectiveness research on limb preservation versus primary amputation in high-risk patients: observational cohort studies and pragmatic randomized trials comparing outcomes of attempted revascularization/advanced wound care strategies against primary amputation in patients with severe ischemia and multiple comorbidities (eg, diabetes, renal failure, congestive heart failure). These studies target the subgroup where the decision to attempt limb salvage is uncertain, measuring functional outcomes, readmission rates, major adverse events, and total episode-of-care costs over 30–90 days to one year. Findings are directly relevant to payers and care teams when deciding initial management pathways that influence downstream costs, rehospitalizations, and quality-adjusted survival for patients assigned to this DRG.
• Post-discharge rehabilitation, prosthetic utilization, and long-term outcomes studies: longitudinal research following patients after inpatient amputation for circulatory disorders to evaluate inpatient discharge planning, timing and access to physical therapy, prosthetic fitting, and community reintegration, as well as rates of contralateral limb events and mortality. These cohort and implementation studies examine how variations in early postoperative rehabilitation, care coordination, and secondary prevention affect readmissions, functional independence, and total cost of care over 6–24 months. Insights help hospitals and payers develop bundled payment strategies, readmission reduction programs, and targeted care transitions to improve outcomes and control costs for this vulnerable DRG group.